期刊文献+

鼠疫噬菌体对感染鼠疫小鼠的疗效 被引量:6

Curative effect of plaque bacteriophage on Yersinia pestis infection in mice
原文传递
导出
摘要 目的观察鼠疫噬菌体对感染鼠疫小鼠的治疗作用,以寻找治疗鼠疫感染的新方法。方法小鼠经皮下感染141株鼠疫菌建立鼠疫感染模型后,用效价为10-11的鼠疫噬菌体对短期治疗组在感染后3、6、12和24 h给予100μl/次的注射治疗,对长期治疗组在感染后1~7 d连续注射鼠疫噬菌体,100μl/次,1次/d。同时,设阴性对照组(不感染,只治疗,观察噬菌体对小鼠的毒性)和阳性对照组(仅感染,不治疗)。结果阴性对照组小鼠治疗14 d后全部存活,处死后剖检未检出鼠疫菌。各治疗组小鼠在治疗第5天存活率为100%,与阳性对照组相比,差异有统计学意义(P<0.05);长期腹腔治疗组效果明显,鼠疫噬菌体在小鼠体内存活时间长,效价不降低。结论鼠疫噬菌体对感染小鼠急性感染期的治疗有一定效果,长期腹腔注射治疗效果较好,为其进一步应用于抗感染治疗提供了实验依据。 Objective To observe the curative effect of plague bacteriophage on Yersinia pestis infection in mice and in-vestigate a novel therapeutic method for plaque.Methods Mouse model of plaque infection was established by subcuta-neous infection with Y.pestis 141 strain.Model mice were treated with 100 μl of plaque bacteriophage at a titer of 10-11 3,6,12 and 24 h after infection to observe the short-term curative effect,or with 100 μl of plaque bacteriophage once a day 1~7 d after infection to observe the long-term curative effect.Uninfected mice were served as negative control to observe the toxicity of bacteriophage,while the infected mice as positive control received no treatment.Results All the mice in negative control group survived 14 d after treatment,in which no Y.pestis was detected.All the survival rates of mice in various test groups were 100% on day 5 after infection,while showed significant difference with that in positive control group(P 〈0.05).Long-term intraperitoneal injection with plaque bacteriophage showed significantly curative effect,while the bacteriophage survived for a long time and showed no decrease in titer.Conclusion Plague bacteriophage showed a certain curative effect on plague at acute infection stage,of which those by long-term intraperitoneal injection showed satisfactory curative effect.It provided an experimental basis for application of plaque bacteriophage to treatment of Y.pestis infection.
出处 《中国生物制品学杂志》 CAS CSCD 2013年第4期531-533,共3页 Chinese Journal of Biologicals
关键词 耶尔森菌 鼠疫 噬菌体 Yesinia pestis Bacteriophage
  • 相关文献

参考文献17

  • 1张永利,万献尧.细菌耐药性研究进展[J].中国医师杂志,2004,6(12):1721-1722. 被引量:34
  • 2Stirrett KL, FerrerasJA,Jayaprakash V, et al, Small molecules with structural similarities to siderophores as novel antimicrobials against Mycobacterium tuberculosis and Y ersinia pestis[n Bioorg Med Chern Lett, 2008, 18 (8): 2662-2668.
  • 3Panchal RG, Ulrich RL, Lane D, et al. Novel broad-spectrum his-I irnidazolinylindole ) derivatives with potent antibacterial activities against antibiotic-resistant strains[J]. Antimicrob Agents Chemother, 2009, 53 (10): 4283-4291.
  • 4Ayyadurai S, Lepidi H, Nappez C, et al. Lovastatin protects against experimental plague in mice[J]. PLoS One, 2010, 5 (6): elO928.
  • 5Welch TJ, Fricke WF, McDermott PF, et al. Multiple antimicr?oresistance in plague: an emerging public health risk[J]. PLoS One, 2007, 2 (3): e309.
  • 6Smiley ST. Current challenges in the development of vaccines for pneumonic plague[n Expert Rev Vaccines, 2008, 7 (2): 209- 221.
  • 7Dublanchet A, Patey O. Bacterial infection-update on phage therapy[Jl. Med Mal Infect, 2008, 38 (8): 407-409.
  • 8Fischetti VA. Bacteriophage lysins as effective antibacterials[J]. Curr Opin Microbiol, 2008, 11 (5): 393-400.
  • 9G6rski A, Miedzybrodzki R, BorysowskiJ, et al. Bacteriophage therapy for the treatment of infections[J]. Curr Opin Investig Drugs, 2009, 10 (8): 766-774.
  • 10Fortuna W, Miedzybrodzki R, Weber-Dabrowska B, et al. Bacteriophage therapy in children: facts and prospects[J]. Med Sci Monit, 2008, 14(8): RAI26-RA132.

二级参考文献16

  • 1Hanes SD,Wood GC,Herring V,et al.Intermittent and continuous ceftazidime infusion for critically ill trauma patients[J]. Am J Surg,2000,179:436-440
  • 2Jones R. Resistance patterns among nosocomial pathogens[J]. Chest,2001,119:397-404
  • 3Murthy R. Implementation of strategies to control antimcrobial resistance[J]. Chest,2001,119:405-411
  • 4Leclercq R. Safeguarding future antimicrobial options: strategies to minimize resistance[J]. Clin Microbiol Infect,2001,7:18-23
  • 5Raymond DP, Pelletier SJ,Crabtree TD,et al. Impact of rotating empiric antibiotic schedule on infectious mortality in an intensive care unit[J]. Crit Care Med,2001,29:1101-1108
  • 6Dunbar,Lala M. Current Issues in the Management of Bacterial Respiratory Tract Disease: The challenge of antibacterial resistance[J]. The American Joural of Medical Science,2003,326⑹:360-368
  • 7Niederman,Michael S. Appropriate use of antimicrobial agents:challenges and strategies for improvent[J]. Critical Care Medicine,2003,31⑵:608-616
  • 8中国生物制品标准化委员会.中华人民共和国卫生行业标准--鼠疫诊断标准WS279-2008[S].北京:人民卫生出版社,2008.
  • 9Mikael Skurnik,Maria Pajunen,Saija Kiljunen. Biotechnological challenges of phage therapy[J] 2007,Biotechnology Letters(7):995~1003
  • 10Anna Przerwa,Micha? Zimecki,Kinga ?wita?a-Jeleń,Krystyna D?browska,Ewa Krawczyk,Miros?aw ?uczak,Beata Weber-D?browska,Danuta Syper,Ryszard Mi?dzybrodzki,Andrzej Górski. Effects of bacteriophages on free radical production and phagocytic functions[J] 2006,Medical Microbiology and Immunology(3):143~150

共引文献66

同被引文献51

  • 1王洪喜,王忠惠,张市,张景林,曹淑兰,陈景和,宋延富.非典型鼠疫菌的获得及特性研究[J].中国地方病防治,1995,10(6):333-335. 被引量:9
  • 2王洪喜,王忠惠,张景林,张市,曹淑兰,陈景和,宋延富.非典型鼠疫耶尔森氏菌及其流行病学意义的研究[J].中国地方病防治,1996,11(2):72-74. 被引量:11
  • 3周本加.青海省海南藏族自治州鼠疫防治50年回顾[J].地方病通报,2006,21(3):45-46. 被引量:16
  • 4周铁丽,林小玲,冯红军,李超,刘庆中,王赛芳,王邦松.鲍氏不动杆菌对亚胺培南耐药机制研究[J].中华医院感染学杂志,2007,17(4):375-378. 被引量:16
  • 5SalmondGP, FineranPC. A century of the phage: past, present and future[J]. Nat Rev Microbiol,2015,13(12):777-786. DOI:10.1038/nrmicro3564.
  • 6KutateladzeM, AdamiaR. Bacteriophages as potential new therapeutics to replace or supplement antibiotics[J]. Trends Biotechnol,2010,28(12):591-595. DOI:10.1016/j.tibtech.2010.08.001.
  • 7ZhuJ, RaoX, TanY, et al. Identification of lytic bacteriophage MmP1, assigned to a new member of T7-like phages infecting Morganella morganii[J]. Genomics,2010,96(3):167-172.DOI:10.1016/j.ygeno.2010.06.001.
  • 8HungCH, KuoCF, WangCH, et al. Experimental phage therapy in treating Klebsiella pneumoniae-mediated liver abscesses and bacteremia in mice[J]. Antimicrob Agents Chemother,2011,55(4):1358-1365. DOI:10.1128/AAC.01123-10.
  • 9CapparelliR, ParlatoM, BorrielloG, et al. Experimental phage therapy against Staphylococcus aureus in mice[J]. Antimicrob Agents Chemother,2007,51(8):2765-2773. DOI:10.1128/AAC.01513-06.
  • 10孟伟,桑俊军,段玉东.体外药敏试验与临床应用差异的原因分析[J].中国医药导报,2008,5(8):120-120. 被引量:3

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部